Literature DB >> 2822795

Effects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal function in normal man.

J M Connell1, J A Whitworth, D L Davies, A F Lever, A M Richards, R Fraser.   

Abstract

Both Adrenocorticotrophin (ACTH) and glucocorticoids raise blood pressure in man and animals, but the relationship of this and altered renal function to other cardiovascular variables, and the differences and similarities of the effects of the two agonists have not been fully explained. The present study compares the effects of ACTH (0.5 mg i.m; every 12 h) and cortisol (50 mg orally, every 6 h) in six normal men over a period of 5 days, preceded and followed by control periods of 3 and 2 days, respectively. Plasma cortisol levels were higher during ACTH treatment than during cortisol treatment. Both treatments raised blood pressure significantly and caused a marked antinatriuresis and expansion of extracellular fluid and plasma volume. ACTH also enhanced potassium excretion but this was less obvious for cortisol. Plasma concentrations of atrial natriuretic peptide rose to more than twice the basal level with both treatments. Both treatments markedly altered renal function. They raised glomerular filtration rate (GFR), i.e. inulin clearance (141% with ACTH; 113% with cortisol) although creatinine clearance was not changed, showing this to be an unreliable index during steroid administration. Filtration fraction (FF) also increased during both treatments, and renal blood flow (RBF) fell, although this achieved statistical significance only during cortisol treatment. Effective renal plasma flow [para-amino hippurate (PAH) clearance] remained unchanged while calculated renal vascular resistance increased. Fractional sodium reabsorption also rose but achieved statistical significance only during ACTH treatment. The similarity of response to treatment suggests that cortisol is largely responsible for the effects of ACTH.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822795

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  31 in total

Review 1.  Mechanisms of hypertension: the expanding role of aldosterone.

Authors:  E Marie Freel; John M C Connell
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

2.  Social support and socioeconomic status interact to predict Epstein-Barr virus latency in women awaiting diagnosis or newly diagnosed with breast cancer.

Authors:  Christopher P Fagundes; Jeanette M Bennett; Catherine M Alfano; Ronald Glaser; Stephen P Povoski; Adele M Lipari; Doreen M Agnese; Lisa D Yee; William E Carson; William B Farrar; William B Malarkey; Min Chen; Janice K Kiecolt-Glaser
Journal:  Health Psychol       Date:  2011-10-17       Impact factor: 4.267

3.  Evidence that high dose cortisol-induced Na+ retention in man is not mediated by the mineralocorticoid receptor.

Authors:  J A Whitworth; J J Kelly
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

4.  Hyperactivity of the hypothalamic-pituitary-adrenal axis in patients with type 2 diabetes and relations with insulin resistance and chronic complications.

Authors:  Ivana Prpić-Križevac; Silvija Canecki-Varžić; Ines Bilić-Ćurčić
Journal:  Wien Klin Wochenschr       Date:  2012-06-26       Impact factor: 1.704

5.  Circadian Misalignment Increases C-Reactive Protein and Blood Pressure in Chronic Shift Workers.

Authors:  Christopher J Morris; Taylor E Purvis; Joseph Mistretta; Kun Hu; Frank A J L Scheer
Journal:  J Biol Rhythms       Date:  2017-03-27       Impact factor: 3.182

Review 6.  Role of the brain melanocortins in blood pressure regulation.

Authors:  Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Taolin Fang; Nicola Aberdein; Cecilia E Perez de Lara; John E Hall
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-06       Impact factor: 5.187

7.  Glucocorticoid therapy for hypotension in the cardiac intensive care unit.

Authors:  K J Millar; R R Thiagarajan; P C Laussen
Journal:  Pediatr Cardiol       Date:  2007-03-20       Impact factor: 1.655

8.  Circadian misalignment increases cardiovascular disease risk factors in humans.

Authors:  Christopher J Morris; Taylor E Purvis; Kun Hu; Frank A J L Scheer
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

9.  GFR-estimation by serum creatinine during glucocorticosteroid therapy.

Authors:  Emil den Bakker; Berend Koene; Joanna A E van Wijk; Isabelle Hubeek; Reinoud Gemke; Arend Bökenkamp
Journal:  Clin Exp Nephrol       Date:  2018-06-09       Impact factor: 2.801

Review 10.  Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.

Authors:  J A P Da Silva; J W G Jacobs; J R Kirwan; M Boers; K G Saag; L B S Inês; E J P de Koning; F Buttgereit; M Cutolo; H Capell; R Rau; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.